TB & NTM
The sharing of content does not indicate endorsement from Respiratory Futures or BTS.
Here you will find a range of resources on TB & NTM. Case Studies and Feature Articles related to TB & NTM are available to read here - simply select 'Filter by' and then TB & NTM.
NTM Network UK was established in 2014 in response to the need for improved management of the rising number of NTM infections identified in clinical...
This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to...
Produced by the UK Health Security Agency, these videos on YouTube look into genome sequencing in tuberculosis. Watch the videos.
The aim of the tuberculosis (TB) action plan 2021 to 2026 is to improve the prevention, detection and control of TB in England. The action plan will...
UK Health Security Agency (UKHSA) series of webinars on the care, management and prevention of TB aimed at those new to working within and across TB...
A UK based resource to support the monitoring and safe use of anti-tuberculosis drugs and second line treatment of multidrug-resistant...
This report from the UK Health Security Agency (UKHSA) presents detailed data on TB case notifications made to the enhanced tuberculosis surveillance...
The MDR-TB Clinical Advice Service provides advice and support to clinicians who encounter MDR-TB. This UK-wide service forms an integral part of our...
BTS Guidelines for the management of NTM-PD were published in 2017. Access the Guideline here.
This Clinical Statement was developed by TB and Ophthalmic specialists to improve and standardise patient care and support those managing patients...
The Middlesex-London Health Unit’s pamphlet Tuberculosis: Not just a Disease of the Past has been translated into a variety of different...
Dr. Zarir Udwadia shares the story of the suffering of one patient diagnosed with Totally Drug Resistant -Tuberculosis (TDR-TB). His mission is to...
This UK-based resource supports the monitoring and safe use of anti-tuberculosis drugs and second line treatment of MDR-TB. Its guidance team...